Your browser doesn't support javascript.
loading
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
Alkan, Ali; Yasar, Arzu; Güç, Zeynep Gülsüm; Gürbüz, Mustafa; Basoglu, Tugba; Sezgin Göksu, Sema; Bugdayci Basal, Fatma; Türk, Haci Mehmet; Özdemir, Özlem; Yesil Çinkir, Havva; Güven, Deniz Can; Kus, Tülay; Türker, Sema; Koral, Lokman; Karakas, Yusuf; Ak, Naziye; Paydas, Semra; Karci, Ebru; Demiray, Atike Gökçen; Demir, Atakan; Alan, Özkan; Keskin, Özge; Nayir, Erdinç; Tanriverdi, Özgür; Yavuzsen, Tugba; Yumuk, Perran Fulden; Ates, Öztürk; Coskun, Hasan Senol; Turhal, Serdar; Çay Senler, Filiz.
Afiliação
  • Alkan A; Medical Oncology, Mugla Sitki Koçman University School of Medicine, Mugla, Turkey.
  • Yasar A; Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.
  • Güç ZG; Medical Oncology, Dokuz Eylül University School of Medicine, Izmir, Turkey.
  • Gürbüz M; Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.
  • Basoglu T; Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
  • Sezgin Göksu S; Medical Oncology, Akdeniz University School of Medicine, Antalya, Turkey.
  • Bugdayci Basal F; Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
  • Türk HM; Medical Oncology, Bezmialem Vakif University School of Medicine, Istanbul, Turkey.
  • Özdemir Ö; Medical Oncology, Izmir Bozyaka Research and Training Hospital, Izmir, Turkey.
  • Yesil Çinkir H; Medical Oncology, Gaziantep University School of Medicine, Gaziantep, Turkey.
  • Güven DC; Medical Oncology, Hacettepe University School of Medicine, Ankara, Turkey.
  • Kus T; Medical Oncology, Dr Ersin Arslan Training and Research Hospital, Gaziantep, Turkey.
  • Türker S; Medical Oncology, Diskapi Yildirim Beyazit Research and Training Hospital, Ankara, Turkey.
  • Koral L; Medical Oncology, Çanakkale Onsekiz Mart University School of Medicine, Çanakkale, Turkey.
  • Karakas Y; Medical Oncology, Bodrum Acibadem Hospital, Mugla, Turkey.
  • Ak N; Department of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey.
  • Paydas S; Medical Oncology, Çukurova University School of Medicine, Adana, Turkey.
  • Karci E; Medical Oncology, Bagcilar Research and Training Hospital, Istanbul, Turkey.
  • Demiray AG; Medical Oncology, Pamukkale University School of Medicine, Denizli, Turkey.
  • Demir A; Medical Oncology, Acibadem Maslak Hospital, Istanbul, Turkey.
  • Alan Ö; Medical Oncology, Tekirdag Public Hospital, Tekirdag, Turkey.
  • Keskin Ö; Medical Oncology, Selçuk University School of Medicine, Konya, Turkey.
  • Nayir E; Medical Oncology, VM Medical Park Mersin Hospital, Mersin, Turkey.
  • Tanriverdi Ö; Medical Oncology, Mugla Sitki Koçman University School of Medicine, Mugla, Turkey.
  • Yavuzsen T; Medical Oncology, Dokuz Eylül University School of Medicine, Izmir, Turkey.
  • Yumuk PF; Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
  • Ates Ö; Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
  • Coskun HS; Medical Oncology, Akdeniz University School of Medicine, Antalya, Turkey.
  • Turhal S; Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey.
  • Çay Senler F; Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.
Eur J Cancer Care (Engl) ; 29(6): e13296, 2020 Nov.
Article em En | MEDLINE | ID: mdl-32864838
ABSTRACT

OBJECTIVE:

Fear of cancer recurrence (FCR) is an important psychological trauma associated with reduction in the quality of life, disruptions in the level of adjustment, emotional distress and anxiety. The purpose of the study was to evaluate the impact of patient-physician relationship on FCR.

METHODS:

The study was designed as a multicentre survey study. The cancer survivors, who were under remission, were evaluated with structured questionnaires. Patient-physician relationship (PPR) scale in which higher scores indicate better relationship and FCR inventory was used.

RESULTS:

Between January and April 2019, 1,580 patients were evaluated. The median age was 57.0 (19-88), and 66% were female. There was high level of FCR scores in 51% of participants. There was a negative correlation between PPR and FCR scores (r = -.134, p < .001). In multivariate analysis, young age, female gender, history of metastasectomy and worse PPR were associated with high levels of FCR.

CONCLUSION:

It is the first data showing the adverse impact of worse PPR on FCR. The strategies to improve the PPR should be practised. In addition, the cancer survivors, who are under the risk of FCR, should be evaluated and managed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Qualitative_research / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Qualitative_research / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article